← Leaderboards
Jessalyn J Baljon
Vanderbilt University
$119,772
Attributed
$119,772
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.8K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$119,772 · 1
By mechanism
F31$119,772 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- John Tanner Wilson$7,006,172
- Manus J Donahue$14,228,730
- Daniel S Perrien$5,036,905
- Sebastian Joyce$13,492,547
- Daniel Oliver Claassen$7,946,566
Others in their field
Other Emerging Leaders on “Educational Status”
- Scott Rusk · Boston University Medical Campus$19,172,606
- Mark Brian Reed · San Diego State University$13,471,024
- Bradley George Phillips · Emory University$11,151,178
- Hongtao Yu · Morgan State University$10,225,294
- James Dale Berry · Brigham And Women'S Hospital$9,819,674
- Alex De Marco · New York Structural Biology Center$9,560,429
Research focus
Educational StatusAdjuvantAgonistDrug Delivery SystemsAntigen-Specific T CellsAntigen PresentationArtificial NanoparticlesAntigen-Presenting CellsAntigensCancer TherapyCancer VaccinesCareerCd8-Positive T-LymphocytesCellular ImmunityChargeChemical PropertyColon CarcinomaCross PresentationCancer ModelDendritic CellsDesignDinucleoside PhosphatesDisadvantagedEfficacy Testing
Grant awards (3)
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines$26,984
F31 · FY2023 · CA · contact PI
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines$46,752
F31 · FY2022 · CA · contact PI
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines$46,036
F31 · FY2021 · CA · contact PI